Press Releases

• Number of shares and votes in Active Biotech
  Jan 30, 2026 11:30 (CET) Regulatory
• Active Biotech’s nomination committee appointed
  Jan 21, 2026 16:15 (CET) Regulatory
• Active Biotech announces outcome in the rights issue
  Dec 10, 2025 20:00 (CET) Regulatory
• Active Biotech’s patent related to a pharmaceutical formulation of tasquinimod will be granted in the US
  Nov 25, 2025 10:00 (CET)
• The subscription period in Active Biotech’s rights issue begins today
  Nov 25, 2025 08:30 (CET) Regulatory